Bian J, Sun Y
Department of Molecular Biology, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, MI 48105, USA.
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14753-8. doi: 10.1073/pnas.94.26.14753.
p53 tumor suppressor protein negatively regulates cell growth, mainly through the transactivation of its downstream target genes. As a sequence-specific DNA binding transcription factor, p53 specifically binds to a 20-bp consensus motif 5'-PuPuPuC(A/T) (T/A)GPyPyPyPuPuPuC(A/T)(T/A)GPyPyPy-3'. We have now identified, partially purified, and characterized an additional approximately 40-kDa nuclear protein, p53CP (p53 competing protein), that specifically binds to the consensus p53 binding sites found in several p53 downstream target genes, including Waf-1, Gadd45, Mdm2, Bax, and RGC. The minimal sequence requirement for binding is a 14-bp motif, 5'-CTTGCTTGAACAGG-3' [5'-C(A/T)(T/A)GPyPyPyPuPuPuC(A/T)(T/A)G-3'], which includes the central nucleotides of the typical p53 binding site with one mismatch. p53CP and p53 (complexed with antibody) showed a similar binding specificity to Waf-1 site but differences in Gadd45 and T3SF binding. Like p53, p53CP also binds both double- and single-stranded DNA oligonucleotides. Important to note, cell cycle blockers and DNA damaging reagents, which induce p53 binding activity, were found to inhibit p53CP binding in p53-positive, but not in p53-negative, cells. This finding suggested a p53-dependent coordinate regulation of p53 and p53CP in response to external stimuli. p53CP therefore could be a third member of the p53 family, in addition to p53 and p73, a newly identified p53 homolog. p53CP, if sequestering p53 from its DNA binding sites through competitive binding, may provide a novel mechanism of p53 inactivation. Alternatively, p53CP may have p53-like functions by binding and transactivating p53 downstream target genes. Cloning of the p53CP gene ultimately will resolve this issue.
p53肿瘤抑制蛋白主要通过其下游靶基因的反式激活来负向调节细胞生长。作为一种序列特异性DNA结合转录因子,p53特异性结合一个20碱基对的共有基序5'-PuPuPuC(A/T)(T/A)GPyPyPyPuPuPuC(A/T)(T/A)GPyPyPy-3'。我们现已鉴定、部分纯化并表征了另一种约40 kDa的核蛋白p53CP(p53竞争蛋白),它能特异性结合在几个p53下游靶基因(包括Waf-1、Gadd45、Mdm2、Bax和RGC)中发现的p53共有结合位点。结合所需的最小序列要求是一个14碱基对的基序5'-CTTGCTTGAACAGG-3' [5'-C(A/T)(T/A)GPyPyPyPuPuPuC(A/T)(T/A)G-3'],它包含典型p53结合位点的中央核苷酸且有一个错配。p53CP和p53(与抗体复合)对Waf-1位点表现出相似的结合特异性,但在Gadd45和T3SF结合上存在差异。与p53一样,p53CP也能结合双链和单链DNA寡核苷酸。值得注意的是,发现诱导p53结合活性的细胞周期阻滞剂和DNA损伤试剂在p53阳性细胞中抑制p53CP结合,但在p53阴性细胞中则不然。这一发现提示在响应外部刺激时p53和p53CP存在p53依赖性的协同调节。因此,除了p53和新鉴定的p53同源物p73外,p53CP可能是p53家族的第三个成员。如果p53CP通过竞争性结合从其DNA结合位点隔离p53,可能会提供一种p53失活的新机制。或者,p53CP可能通过结合并反式激活p53下游靶基因而具有类似p53的功能。p53CP基因的克隆最终将解决这个问题。